Anyone should be able to initiate medical research that matters to them.
Getting to know MiRcore
MiRcore is a 501(c)(3) non-profit research organization with a vision of global, multilateral collaboration toward treating individuals based on their unique genetic profiles and environmental circumstances. We are certain that getting beyond the single-gene approach is critical to replacing current trial and error processes with systematic, personalized medicine. While systems biologists are now undertaking sophisticated mapping of genetic networks while taking into account environmental effects such as infection, exercise, sleep, and stress, there remains the challenge of increasing the signal-to-noise ratio when dealing with massive amounts of biological data.
We support your research through our insight into microRNA (miRNA) function. The primary goal of these collaborative efforts is to produce research papers presenting readily testable hypotheses. Significant results will allow pursuit of grant applications and patents. Our efforts will be compensated following a fee-based schedule until mutual grants or subcontracts are in place. You can consult without hiring. We ask for co-authorship if our analyses significantly contribute to your research.
Getting to know GIDAS
GIDAS: A network of school clubs fulfilling miRcore’s outreach component, which aims to connect the general public with scientists.
Current organized High School GIDAS chapters: Huron, Pioneer, Community, and Skyline High Schools in Ann Arbor, Michigan Milan, International Academy West, International Academy East, Farmington High Schools, Michigan
High school GIDAS chapters in progress: Greenhills, Plymouth, Chelsea High schools, Michigan
miRcore is a 501(c)(3) research organization with a vision of democratizing medical research so that anyone can initiate medical research that matters to them. We value science, compassion, and efficiency. We will keep working to bring about personalized medicine as common practice.
Once a year, we provide microgrants to innovative research on the year’s disease of focus. The winners will be voted on by 1) members and 2) donors.